(Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-N-propyl-1H-pyrrole-3-carboxamide

ID: ALA4795455

PubChem CID: 58589750

Max Phase: Preclinical

Molecular Formula: C19H20FN3O2

Molecular Weight: 341.39

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C

Standard InChI:  InChI=1S/C19H20FN3O2/c1-4-7-21-19(25)17-10(2)16(22-11(17)3)9-14-13-8-12(20)5-6-15(13)23-18(14)24/h5-6,8-9,22H,4,7H2,1-3H3,(H,21,25)(H,23,24)/b14-9-

Standard InChI Key:  KXDZRRYKOICUNG-ZROIWOOFSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   28.1566   -4.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1554   -4.9565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8703   -5.3693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8684   -3.7163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5838   -4.1254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5841   -4.9565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3746   -5.2131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8629   -4.5405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3741   -3.8685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4421   -3.7167    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.6288   -3.0838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6879   -4.5403    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.4363   -2.9135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9879   -3.5249    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.7398   -3.1893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6530   -2.3703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8474   -2.2001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5110   -1.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2655   -1.8177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0504   -2.0718    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.0932   -1.0109    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.4547   -3.6010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6629   -1.5192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4477   -1.7733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0603   -1.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  1 10  1  0
  9 11  2  0
 11 13  1  0
  8 12  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  2  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 19 21  2  0
 15 22  1  0
 20 23  1  0
 23 24  1  0
 24 25  1  0
M  END

Associated Targets(Human)

PRKAA1 Tclin AMP-activated protein kinase, alpha-1 subunit (2493 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMP-activated protein kinase, alpha-2 subunit (1328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 341.39Molecular Weight (Monoisotopic): 341.1540AlogP: 3.40#Rotatable Bonds: 4
Polar Surface Area: 73.99Molecular Species: NEUTRALHBA: 2HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.46CX Basic pKa: CX LogP: 3.07CX LogD: 3.07
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -1.04

References

1. Matheson CJ,Casalvieri KA,Backos DS,Minhajuddin M,Jordan CT,Reigan P.  (2020)  Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors.,  197  [PMID:32334266] [10.1016/j.ejmech.2020.112316]

Source